Drug General Information
Drug ID
D03IYT
Former ID
DCL000962
Drug Name
Rimonbant
Synonyms
Acomplia; Rimonabant; Acomplia (TN); Rimonabant (JAN/USAN/INN)
Drug Type
Small molecular drug
Indication Obesity [ICD9: 278; ICD10:E66] Withdrawn from market [536710]
Company
Sanofi-aventis
Structure
Download
2D MOL

3D MOL

Formula
C22H21Cl3N4O
Canonical SMILES
CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(<br />C=C4)Cl
InChI
1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)
InChIKey
JZCPYUJPEARBJL-UHFFFAOYSA-N
CAS Number
CAS 158681-13-1
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
A08AX01
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Antagonist [536710]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 536710Anti-obesity drugs. Expert Opin Pharmacother. 2008 Jun;9(8):1339-50.
Ref 536710Anti-obesity drugs. Expert Opin Pharmacother. 2008 Jun;9(8):1339-50.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.